Verition Fund Management LLC Has $332,000 Stake in Simulations Plus, Inc. (NASDAQ:SLP)

Verition Fund Management LLC grew its holdings in Simulations Plus, Inc. (NASDAQ:SLP) by 120.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,365 shares of the technology company’s stock after purchasing an additional 5,665 shares during the quarter. Verition Fund Management LLC’s holdings in Simulations Plus were worth $332,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Dimensional Fund Advisors LP grew its holdings in Simulations Plus by 10.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after buying an additional 37,992 shares during the last quarter. Tributary Capital Management LLC boosted its position in shares of Simulations Plus by 54.7% in the third quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock valued at $10,425,000 after acquiring an additional 115,122 shares during the period. Royce & Associates LP grew its stake in shares of Simulations Plus by 28.8% in the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock worth $7,602,000 after acquiring an additional 53,092 shares during the last quarter. Bank of New York Mellon Corp increased its position in Simulations Plus by 5.2% during the second quarter. Bank of New York Mellon Corp now owns 222,317 shares of the technology company’s stock worth $10,809,000 after acquiring an additional 11,048 shares during the period. Finally, Congress Asset Management Co. raised its stake in Simulations Plus by 22.5% during the 3rd quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock valued at $6,613,000 after purchasing an additional 37,914 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Stock Down 3.1 %

Shares of Simulations Plus stock opened at $30.93 on Friday. Simulations Plus, Inc. has a 12-month low of $27.07 and a 12-month high of $51.22. The stock has a market capitalization of $620.77 million, a P/E ratio of 63.12 and a beta of 0.76. The company has a 50-day simple moving average of $30.79 and a 200 day simple moving average of $36.55.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company’s revenue was up 19.9% on a year-over-year basis. During the same quarter last year, the business posted $0.18 earnings per share. On average, equities analysts anticipate that Simulations Plus, Inc. will post 1.1 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on SLP shares. StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, November 6th. BTIG Research cut their target price on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. Finally, Stephens began coverage on shares of Simulations Plus in a research note on Friday, November 15th. They set an “overweight” rating and a $39.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $51.40.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $27.66, for a total value of $553,200.00. Following the completion of the sale, the director now owns 3,462,584 shares in the company, valued at approximately $95,775,073.44. This trade represents a 0.57 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In the last quarter, insiders sold 60,750 shares of company stock worth $1,837,255. 20.90% of the stock is currently owned by insiders.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.